Search

Search Constraints

You searched for: Author/Creator Iversen Line author non-byline.

Search Results

1. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Issue 1 (23rd October 2014)

2. Digital ulcers predict a worse disease course in patients with systemic sclerosis. Issue 4 (16th February 2015)

3. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Issue 1 (27th August 2014)

4. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Issue 7 (9th April 2019)

5. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Issue 7 (9th July 2019)

6. Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database. Issue 6 (30th June 2014)

7. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Issue 9 (21st June 2019)

8. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Issue 9 (21st September 2019)

9. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Issue 5 (11th May 2019)

10. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Issue 5 (9th March 2019)